OTCMKTS:RLMD

Relmada Therapeutics Stock Predictions

etoro logo Buy RLMD
*Your capital is at risk
$6.33
-0.0900 (-1.40%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RLMD Prediction Chart

RLMD Predictions History

Latest community submissions for RLMD.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 5, 2023 $3.72 +292.22% Unrealistic Excluded from avg $3.78 X 98.32% 1
JS JS Pro
Sep 5, 2023 $3.72 +292.61% Unrealistic Excluded from avg $3.78 X 98.41% 1
Sep 5, 2023 Bullish $3.78 V 0
JS JS Pro
May 30, 2023 $2.98 +305.44% Unrealistic Excluded from avg $2.97 V 99.66% 5
May 30, 2023 $3.04 +314.21% Unrealistic Excluded from avg $2.97 V 97.49% 1
May 30, 2023 $3.01 +308.88% Unrealistic Excluded from avg $2.97 V 98.81% 2
JS JS Pro
Oct 3, 2022 $36.19 +389.05% Unrealistic Excluded from avg $35.44 X 97.88% 1
Oct 3, 2022 $36.04 +387.05% Unrealistic Excluded from avg $35.44 X 98.30% 1
Oct 3, 2022 $33.18 +348.38% Unrealistic Excluded from avg $35.44 X 93.62% 1
Oct 3, 2022 Bullish $35.44 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RLMD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT RELMADA THERAPEUTICS, INC.
Relmada Therapeutics
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE